Cite
MLA Citation
JD Reveille et al.. “AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 1295–1296. http://access.bl.uk/ark:/81055/vdc_100135138966.0x000062